Dr. Jeanne Bolger to chair Board of Directors of Belgium-based vaccine technology company AstriVax

Dr Jeanne Bolger brings over 35 years of management experience in the pharmaceutical industry to the new Belgium-based vaccine technology company.Last month, AstriVax closed its funding round - led by

Related Keywords

Leuven ,Region Flamande ,Belgium ,Ireland ,Irish ,Ackermans Van Haaren ,Kostenloser Wertpapierhandel ,Johan Neyts ,Jeanne Bolger ,Hanne Callewaert ,Kai Dallmeier ,Glaxosmithkline ,Ku Leuven Rega Institute ,Johnson ,V Bio Ventures ,Astrivax Board ,Rega Institute ,Professor Johan Neyts ,Flanders Future Techfund ,Thuja Capital ,Jeanne ,Holger ,Hair ,Board ,Directors ,Ased ,Vaccine ,Technology ,Company ,Astrivax ,